Illinoismed spa & injectable regulations
What’s changing for med spas and injectors in Illinois — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Illinois. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest Illinois changes
- CRITICALLegiScan2025-01-07
IL HB4281: CERTIFIED MEDICAL ESTHETICIAN
Licensed estheticians may now provide more services independently.
Federal changes that apply in Illinois
FDA and Federal Register actions are nationwide — they govern Illinois practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in Illinois
- Illinois legislature — bills on injectables, GLP-1s & scope of practice
- Illinois Board of Nursing — injector scope & delegation
- Illinois Medical Board — physician supervision & ownership rules
- Illinois Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Illinois med spa compliance — FAQ
- Where do Illinois med spa and injectable regulations come from?
- Illinois med spas and injectors are governed by a mix of state and federal authorities — the Illinois legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Illinois and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Illinois?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Illinois. We track those federal changes alongside any Illinois-specific rules so you see the full picture for your practice.
- How do I keep up with Illinois regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Illinois, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a Illinois change
Get the free weekly Brief on what changed across Illinois, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.